Detection of mild inherited disorders of blood coagulation: current options and personal recommendations

被引:23
作者
Lippi, Giuseppe [1 ]
Pasalic, Leonardo [2 ,3 ]
Favaloro, Emmanuel J. [2 ]
机构
[1] Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy
[2] Westmead Hosp, Inst Clin Pathol & Med Res ICPMR, Dept Haematol, Pathol West NSW Hlth Pathol, Westmead, NSW 2145, Australia
[3] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia
关键词
bleeding; blood coagulation; coagulation factor; deficiency; hemophilia; platelet dysfunction; von Willebrand disease; VON-WILLEBRAND-DISEASE; RARE BLEEDING DISORDERS; PARTIAL THROMBOPLASTIN TIME; IMPAIRED PRIMARY HEMOSTASIS; PLATELET-FUNCTION; LABORATORY IDENTIFICATION; LUPUS ANTICOAGULANTS; RECENT GUIDELINES; PRACTICAL CONCEPT; HEMOPHILIA-A;
D O I
10.1586/17474086.2015.1039978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although assessment of prior personal and familial bleeding history is an important aspect of the diagnosis of bleeding disorders, patients with mild inherited bleeding disorders are sometimes clinically asymptomatic until presented with a hemostatic challenge. However, bleeding may occur after incursion of trauma or surgery, so detection of these conditions reflects an important facet of clinical and laboratory practice. Mild bleeding disorders may be detected as a result of family studies or following identification of abnormal values in first-line screening tests such as activated partial thromboplastin time, prothrombin time, fibrinogen and global platelet function screen testing, such as the platelet function analyzer. Following determination of abnormal screening tests, subsequent investigation should follow a systematic approach that targets specific diagnostic tests, and including factor assays, full platelet function assays and more extensive specialized hemostasis testing. The current report provides a personal overview on inherited disorders of blood coagulation and their detection.
引用
收藏
页码:527 / 542
页数:16
相关论文
共 109 条
[41]   Laboratory testing for bleeding disorders: strategic uses of high and low-yield tests [J].
Hayward, C. P. M. ;
Moffat, K. A. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (03) :322-333
[42]   Laboratory Investigations for Bleeding Disorders [J].
Hayward, Catherine P. M. ;
Moffat, Karen A. ;
Liu, Yang .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (07) :742-751
[43]   Platelet-based coagulation: different populations, different functions [J].
Heemskerk, J. W. M. ;
Mattheij, N. J. A. ;
Cosemans, J. M. E. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) :2-16
[44]   Procoagulant Platelets and the Pathways Leading to Cell Death [J].
Hua, Vu Minh ;
Chen, Vivien Mun Yee .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (04) :405-412
[45]   Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency [J].
James, P. ;
Salomon, O. ;
Mikovic, D. ;
Peyvandi, F. .
HAEMOPHILIA, 2014, 20 :71-75
[46]   Platelet heterogeneity - Variation in coagulation complexes on platelet subpopulations [J].
Kempton, CL ;
Hoffman, M ;
Roberts, HR ;
Monroe, DM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (04) :861-866
[47]   Factor XII: a drug target for safe interference with thrombosis and inflammation [J].
Kenna, Ellinor ;
Renne, Thomas .
DRUG DISCOVERY TODAY, 2014, 19 (09) :1459-1464
[48]   Mixing Tests: Diagnostic Aides in the Investigation of Prolonged Prothrombin Times and Activated Partial Thromboplastin Times [J].
Kershaw, Geoffrey ;
Orellana, Daniel .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (03) :283-290
[49]   Laboratory identification of factor inhibitors: an update [J].
Kershaw, Geoffrey ;
Favaloro, Emmanuel J. .
PATHOLOGY, 2012, 44 (04) :293-302
[50]   A practical concept for preoperative identification of patients with impaired primary hemostasis [J].
Koscielny, J ;
Ziemer, S ;
Radtke, H ;
Schmutzler, M ;
Pruss, A ;
Sinha, P ;
Salama, A ;
Kiesewetter, H ;
Latza, R .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2004, 10 (03) :195-204